Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 19;14(7):1499.
doi: 10.3390/pharmaceutics14071499.

Efficacy and Safety of Topical Morphine: A Narrative Review

Krzysztof Nosek  1 , Wojciech Leppert  2   3 , Łukasz Puchała  1 , Krzysztof Łoń  1
Affiliations
Review

Efficacy and Safety of Topical Morphine: A Narrative Review

Krzysztof Nosek et al. Pharmaceutics. .

Abstract

Background: Opioids are the cornerstone of the therapy used in both acute and chronic pain syndromes to treat pain of moderate to severe intensity. The knowledge that opioid receptors also occur in other tissues outside the central nervous system has created a possibility for the topical use of opioids. Thus, local analgesia may be obtained without systemic adverse effects.

Methods: A narrative review of scientific papers discussing the topical use of morphine was conducted. For this purpose, the PubMed, Google Scholar, Cochrane Library, and Mendeley databases were searched.

Results: The current knowledge on topical morphine does not allow for its recommended use in everyday medical practice, but suggests it may be effective, particularly in the treatment of ulcers and erosions of inflammatory etiology and painful skin lesions including persistent post-mastectomy pain due to breast cancer.

Conclusions: Topical morphine has its place beside other analgesics. An important issue is the practical possibility to meet the demand for topical formulations, which is limited by technical difficulties.

Keywords: adverse effects; analgesia; topical morphine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Wordliczek J., Kotlinska-Lemieszek A., Leppert W., Woron J., Dobrogowski J., Krajnik M., Przeklasa-Muszyńska A., Jassem J., Drobnik J., Wrzosek A., et al. Pharmacotherapy of pain in cancer patients—recommendations of the Polish Association for the Study of Pain, Polish Society of Palliative Medicine, Polish Society of Oncology, Polish Society of Family Medicine, and Polish Society of Anaesthesiology and Intensive Therapy. Pol. J. Surg. 2018;18:11–53. doi: 10.5604/01.3001.0010.8160. - DOI - PubMed
    1. Back N.I., Finlay I. Analgesic effect of topical opioids on painful skin ulcers. J. Pain Symptom Manag. 1995;10:493. doi: 10.1016/0885-3924(95)00101-4. - DOI - PubMed
    1. Flock P. Pilot Study to Determine the Effectiveness of Diamorphine Gel to Control Pressure Ulcer Pain. J. Pain Symptom Manag. 2003;25:547–554. doi: 10.1016/S0885-3924(03)00140-4. - DOI - PubMed
    1. Twycross R. Twycross R. Pain Relief in Advanced Cancer. Churchill Livingstone; Edinburgh, UK: 1994. Oral morphine; pp. 307–322.
    1. Bigliardi P.L., Tobin D.J., Gaveriaux–Ruff C., Bigliardi–Qi M. Opioids and the skin—Where do we stand? Exp. Dermatol. 2009;18:424–430. doi: 10.1111/j.1600-0625.2009.00844.x. - DOI - PubMed

LinkOut - more resources